A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

Clinical trial NCT06438263 · COMPLETED

Trial details

NCT number: NCT06438263
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-08-06
Primary completion: 2025-05-03
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.